Search
Healthy Paid Clinical Trials in New Jersey
A listing of 12 Healthy clinical trials in New Jersey actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 12 of 12
The state of New Jersey currently has 12 active clinical trials seeking participants for Healthy research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Healthy Volunteer Trials
Recruiting
Healthy trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Healthy
Featured Trial
Chronic Cough Clinical Study
Recruiting
We are evaluating an investigational treatment to see if it may help people dealing with chronic cough.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.
Eligible participants will receive study-related medical care at no cost. You may be compensated for study-related travel and time. Health insurance is not required. If you qualify, you may receive:
Payment up to $1500, which varies by study.
Conditions:
Cough
Chronic Cough
Asthma
Allergic Asthma
Sinusitis
Featured Trial
COVID-19 Vaccination for Children
Recruiting
The purpose of this clinical trial is to evaluate a booster dose of mRNA-1273.815, Moderna’s investigational COVID-19 vaccine, to learn more about whether the investigational vaccine is safe when given as a booster that is the same dose as an initial COVID-19 vaccination.
Featured Trial
Cardiovascular Disease Trials
Recruiting
Cardiovascular Disease trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Cardiovascular Disease
Featured Trial
Overweight Trials
Recruiting
Overweight trials near you are looking for participants to help push medical research forward. Click through to learn more!
Conditions:
Overweight
A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease
Recruiting
The primary purpose of the study is to evaluate the safety and tolerability of emraclidine administered orally to healthy elderly participants in Part A (multiple ascending doses) and participants with dementia due to Alzheimer's disease (AD) in Part B.
Gender:
All
Ages:
Between 55 years and 90 years
Trial Updated:
06/21/2024
Locations: Marlton, New Jersey, Marlton, New Jersey +1 locations
Conditions: Healthy Participants, Alzheimer's Disease Dementia
A Study to Learn About Whether BAY H006689 Causes an Allergic Reaction When Applied as a Topical Gel in Healthy Participants
Recruiting
Researchers are looking for a better way to treat muscle and joint pain. Researchers have seen that medicines which help reduce pain and inflammation could be safer when applied directly to the skin, called topical application, than when taken by mouth. However, recent studies have found that using these medicines on the skin can sometimes cause skin reactions such as redness, itching, or irritation in the area where the medicine is applied. However, reports of more serious side effects, affecti... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/14/2024
Locations: TKL Research, Inc., Fair Lawn, New Jersey
Conditions: Pain, Healthy Volunteers
Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence Tomography in Healthy Skin
Recruiting
The goal of this study is to visualize the deposition of topical 0.3% roflumilast (Zoryve) compared to vehicle using Line-Field Optical Coherence Tomography (LC-OCT) in vivo in healthy skin. We hypothesize that the application of topical 0.3% roflumilast (Zoryve) will result in distinct patterns of deposition within the epidermal and dermal layers compared to the vehicle. Specifically, we anticipate observing deeper penetration and more uniform distribution of roflumilast within the skin layers,... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
05/28/2024
Locations: Rao Dermatology, Atlantic Highlands, New Jersey
Conditions: Healthy Skin
Postprandial Inflammation and Nuts (PIN) in Older Adults
Recruiting
The aging population is rapidly increasing, and it is important to identify dietary factors that can prevent disease and promote health in this group. Legumes, such as peanuts, are a plant-based food high in protein and unsaturated fat making this a healthy choice, but are not consumed frequently enough in older adults. Studies have shown that regular nut consumption is associated with lower adiposity and reduced weight gain and inflammation. Given these findings, this study will examine the pos... Read More
Gender:
All
Ages:
55 years and above
Trial Updated:
05/09/2024
Locations: Foran Hall, New Brunswick, New Jersey +1 locations
Conditions: Healthy Aging, Overweight and Obesity
Single Ascending Dose Study of NRS 033 in Healthy Volunteers
Recruiting
This is a phase 1, first in human, randomized, double-blind, placebo-controlled, single ascending dose (SAD) study in healthy adult male and female subjects 18 to 55 years of age, inclusive.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
05/01/2024
Locations: Frontage Clinical Research Center, Secaucus, New Jersey
Conditions: Healthy Volunteers
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood Obesity
Recruiting
Parents are children's primary role models, are food and physical activity gatekeepers, and create the structure/lifestyle environment within the home. Thus, parents strongly influence children's weight-related behaviors and have the opportunity to cultivate a "culture of health" within the home. Yet, there continues to be a dearth of evidence-based obesity prevention intervention programs, especially for families with children aged 6 to 11 years, commonly called the middle childhood years. The... Read More
Gender:
All
Ages:
Between 24 years and 50 years
Trial Updated:
04/04/2024
Locations: Rutgers University, New Brunswick, New Jersey
Conditions: Healthy Lifestyle, Home Environment Related Disease, Cognitive Change, Child Behavior, Child Obesity, Parenting, Parents, Parent-Child Relations
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)
Recruiting
The purpose of this study is to assess the pharmacokinetics, safety, and tolerability following multiple ascending oral doses of ABBV-932 or placebo in healthy adult participants, participants with Generalized Anxiety Disorder (GAD), and participants with bipolar disorder (BPD).
Gender:
All
Ages:
Between 18 months and 65 years
Trial Updated:
02/12/2024
Locations: CenExel HRI /ID# 260271, Marlton, New Jersey
Conditions: Healthy Volunteers, Generalized Anxiety Disorder (GAD), Bipolar Disorder (BPD)
Comparing Targets of Expressive Writing
Recruiting
Expressive writing (Pennebaker & Beall, 1986) involves writing about one's deepest thoughts and feelings surrounding an emotional event. The current literature on the efficacy of expressive writing is mixed and warrants further investigation into how, when, and for whom expressive writing is an effective intervention. The goal of this study is to compare the efficacy of expressive writing interventions in young adults when people imagine that they're writing to themselves vs. a loved one. Partic... Read More
Gender:
All
Ages:
Between 18 years and 25 years
Trial Updated:
11/06/2023
Locations: Peretsman Scully Hall, Princeton, New Jersey
Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults
Recruiting
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ciraparantag for reversal of anticoagulation induced by different anticoagulant drugs in generally healthy adults as measured primarily by an automated coagulometer device.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
07/18/2023
Locations: Frontage Clinical Services, Secaucus, New Jersey
Conditions: Healthy
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy Participants
Recruiting
CB03-154 is an investigational drug developed by Shanghai Zhimeng Biopharma Inc. for the treatment of Epilepsy.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
08/14/2022
Locations: Frontage Clinical Services, Inc., Secaucus, New Jersey
Conditions: Healthy Volunteers
Telerehabilitation Alzheimer's Disease Feasibility (TADF)
Recruiting
This is a pilot RCT with equal arms: experimental arm and (wait list) control arm.
All participants will be in the early stage of Alzheimer's disease and on stable medication. They will all continue with this medication for their 6 months participation.
Experimental group will add weekly training on the experimental device, 5 days a week for 8 weeks. Training will involve therapeutic games aimed primarily at the memory cognitive domain. All participants will receive weekly calls from clinical... Read More
Gender:
All
Ages:
Between 65 years and 85 years
Trial Updated:
04/26/2022
Locations: Rutgers, The State University of New Jersey, New Brunswick, New Jersey +1 locations
Conditions: Alzheimer Disease, Healthy Aging
A Study Investigating Lu AG22515 in Healthy Adults
Recruiting
The main goal of this study is to learn more about the safety of a drug called Lu AG22515. During the trial, healthy adult participants will receive a single dose of Lu AG22515 or a placebo (normal saline solution).
Gender:
All
Ages:
Between 19 years and 60 years
Trial Updated:
03/21/2022
Locations: Frontage Clinical Services, Inc., Secaucus, New Jersey
Conditions: Healthy Participants